Webinar: The EU – Why it’s a Strategic Destination for Running Clinical Trials

📅 14 April 2026
⏱️ 9am – GMT

As global healthcare continues to evolve at pace, the demand for faster access to innovative treatments for critical illnesses has never been greater. Identifying the right locations for clinical trials is now a key strategic priority, as sponsors work to meet the needs of expanding markets while maintaining efficiency and quality. With the growing demand for more advanced therapies, the importance of cost-effective, high-performing clinical trial environments is only increasing, placing the EU firmly in the spotlight as a preferred destination.

In this must-watch webinar, Zayheda Khan, Chief Commercial Officer and UK Managing Director at Oximio, and Alla Nemchenko, Business Development Manager, will be joined by Nigel Goodman, CEO of Gaea OÜ. Together, they will examine the current market landscape, provide a clear overview of the EU regulatory framework, and highlight the key advantages the region offers to clinical trial sponsors.

Don’t miss out. Register today for this free webinar and gain valuable insights into how the EU can support your clinical trial strategy.